Home/Filings/4/0001104659-20-080568
4//SEC Filing

Partners Innovation Fund, LLC 4

Accession 0001104659-20-080568

CIK 0001722271other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:17 PM ET

Size

15.8 KB

Accession

0001104659-20-080568

Insider Transaction Report

Form 4
Period: 2020-06-30
Transactions
  • Conversion

    Common Stock

    2020-06-30+342,505445,256 total
  • Conversion

    Common Stock

    2020-06-30+102,751102,751 total
  • Conversion

    Common Stock

    2020-06-30+119,997565,253 total
  • Conversion

    Series A Preferred Stock

    2020-06-30342,5050 total
    Common Stock (342,505 underlying)
  • Conversion

    Series Seed Preferred Stock

    2020-06-30102,7510 total
    Common Stock (102,751 underlying)
  • Conversion

    Series B Preferred Stock

    2020-06-30119,9970 total
    Common Stock (119,997 underlying)
Footnotes (4)
  • [F1]On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F2]The securities are held by Partners Innovation Fund, LLC ("PIF"). PIF is a limited liability company controlled by its members. The Members of PIF are (1) The General Hospital Corporation (commonly referred to as "MGH"), (2) Brigham and Women's Hospital and (3) Massachusetts Eye and Ear.
  • [F3]On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F4]On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Documents

1 file

Issuer

Akouos, Inc.

CIK 0001722271

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001816128

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:17 PM ET
Size
15.8 KB